These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33864519)

  • 1. Immunohistochemical localization and pharmacokinetics of the anti-MRSA drug teicoplanin in rat kidney using a newly developed specific antibody.
    Yamamoto Y; Yamamoto Y; Saita T; Shin M
    Med Mol Morphol; 2021 Sep; 54(3):227-236. PubMed ID: 33864519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemistry for vancomycin using a monoclonal antibody that reveals accumulation of the drug in rat kidney and liver.
    Fujiwara K; Yoshizaki Y; Shin M; Miyazaki T; Saita T; Nagata S
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5883-91. PubMed ID: 22948874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
    Fujiwara K; Shin M; Matsunaga H; Saita T; Larsson LI
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3302-7. PubMed ID: 19451299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the pharmacokinetics of teicoplanin in patients with hyperglycaemic hypoalbuminaemia: Impact of albumin glycosylation on the binding of teicoplanin to albumin.
    Enokiya T; Muraki Y; Iwamoto T; Okuda M
    Int J Antimicrob Agents; 2015 Aug; 46(2):164-8. PubMed ID: 25982916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Localization and Accumulation Studies of Daptomycin in Rats Kidney Using Immunohistochemistry].
    Yamamoto Y; Yamamoto Y; Saita T; Shin M
    Yakugaku Zasshi; 2020; 140(4):569-576. PubMed ID: 32238639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of Teicoplanin on the PT-INR Controlled by Warfarin in Infection Patients].
    Nakano T; Nakamura T; Nakamura Y; Irie K; Sato K; Matsuo K; Imakyure O; Ogata K; Mishima K; Kamimura H
    Yakugaku Zasshi; 2017; 137(7):909-916. PubMed ID: 28674307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical Pharmacokinetics of the Anti-diabetes Drug Alogliptin in Rat Kidney and Liver.
    Yamamoto Y; Yamamoto Y; Saita T; Hira D; Chijiwa T; Shin M
    Acta Histochem Cytochem; 2020 Jun; 53(3):55-60. PubMed ID: 32624630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis.
    Nakano T; Nakamura Y; Takata T; Irie K; Sano K; Imakyure O; Mishima K; Futagami K
    Int J Clin Pharm; 2016 Aug; 38(4):908-14. PubMed ID: 27125378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of breakthrough Gram-positive cocci infection during vancomycin vs teicoplanin therapy in patients receiving haematopoietic stem cell transplantation.
    Ohata K; Kitagawa J; Niwa T; Takahashi-Yamauchi T; Harada S; Matsumoto T; Nakamura N; Nakamura H; Kanemura N; Shimizu M; Suzuki A
    J Clin Pharm Ther; 2020 Dec; 45(6):1342-1348. PubMed ID: 32656902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical analysis of the adverse effects of glycopeptide antibiotics, based on pharmacokinetics and toxicokinetics (PK/TK).
    Yoshida M; Matzno S; Namba H; Nishikata M; Matsuyama K
    J Infect Chemother; 2006 Jun; 12(3):114-8. PubMed ID: 16826342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination effect of teicoplanin and panipenem on highly resistant strains of MRSA].
    Utsui Y; Ishii C; Abe T; Kakuta M; Ohya S
    Jpn J Antibiot; 1999 Mar; 52(3):268-77. PubMed ID: 10367264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibility of Poor Outcomes after Treatment Using Teicoplanin at the Minimum Inhibitory Concentration of >2 μg/mL in Methicillin-resistant Staphylococcus aureus Bacteremia].
    Kagami K; Imai S; Tazawa Y; Iwasaki S; Fukumoto T; Akizawa K; Yamada T; Ishiguro N; Iseki K
    Yakugaku Zasshi; 2018; 138(9):1181-1189. PubMed ID: 30175762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of Predictivity of Teicoplanin Serum Trough Concentrations at Steady State Calculated by Vancomycin Pharmacokinetic Parameter.
    Kobayashi R; Otomo S; Shiba Y; Ebinuma K; Sudoh T
    Yakugaku Zasshi; 2016; 136(11):1557-1562. PubMed ID: 27803487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specific variability of teicoplanin protein binding in patients receiving continuous hemodiafiltration-comparison with hypoalbuminemia patients].
    Yanagimoto H; Teramatsu T; Goto J; Yanagisawa M; Harii N; Suzuki M; Hanawa T; Matsuda K; Oguchi T
    Yakugaku Zasshi; 2013; 133(6):711-7. PubMed ID: 23558910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial effects of brand-name teicoplanin and generic products against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Fujimura S; Fuse K; Takane H; Nakano Y; Gomi K; Kikuchi T; Watanabe A
    J Infect Chemother; 2011 Feb; 17(1):30-3. PubMed ID: 20665064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of teicoplanin dosing designs to achieve a new target trough concentration.
    Ueda T; Takesue Y; Nakajima K; Ichki K; Wada Y; Tsuchida T; Takahashi Y; Ishihara M; Tatsumi S; Kimura T; Ikeuchi H; Uchino M
    J Infect Chemother; 2012 Jun; 18(3):296-302. PubMed ID: 22065089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections.
    Nakamura A; Takasu O; Sakai Y; Sakamoto T; Yamashita N; Mori S; Morita T; Nabeta M; Hirayu N; Yoshiyama N; Moroki M; Tashiro K; Kannae M
    J Infect Chemother; 2015 Jun; 21(6):449-55. PubMed ID: 25726436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)].
    Hatano K; Yokota Y; Hanaki H; Sunakawa K
    Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody.
    Balen D; Ljubojevic M; Breljak D; Brzica H; Zlender V; Koepsell H; Sabolic I
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C475-89. PubMed ID: 18524944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination effect of teicoplanin and beta-lactams on MRSA].
    Otsuka Y; Yoshibe T; Namioka M; Ezaki T
    Jpn J Antibiot; 2000 Dec; 53(12):643-51. PubMed ID: 11234220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.